The head of the FMBA said that the report on the second phase of the Mir-19 research was submitted to the Ministry of Health

“The report on the second phase has been submitted to the Ministry of Health, and we, accordingly, are waiting for the completion of the registration procedure for the drug,” Skvortsova said.

Earlier, the press service of the FMBA stated that the registration of the drug for the coronavirus "MIR 19" is expected by the end of the year.

Virologist Yevgeny Timakov, in an interview with FAN, gave a forecast on the situation with COVID-19 before the New Year holidays.